The Manufacturers Life Insurance Company Buys Shares of 339,490 Corteva, Inc. $CTVA

The Manufacturers Life Insurance Company purchased a new position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 339,490 shares of the company's stock, valued at approximately $28,750,000. The Manufacturers Life Insurance Company owned about 0.05% of Corteva as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of CTVA. Compass Financial Management LLC acquired a new position in Corteva during the 2nd quarter valued at $25,000. JPL Wealth Management LLC acquired a new stake in Corteva in the 3rd quarter worth $25,000. Garton & Associates Financial Advisors LLC bought a new position in shares of Corteva during the 4th quarter worth about $27,000. Bank of Jackson Hole Trust acquired a new position in shares of Corteva during the fourth quarter valued at about $28,000. Finally, Cornerstone Financial Management LLC bought a new stake in shares of Corteva in the fourth quarter valued at about $29,000. 81.54% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CTVA shares. Royal Bank Of Canada upped their price target on Corteva from $97.00 to $103.00 and gave the company an "outperform" rating in a report on Tuesday, July 21st. Jefferies Financial Group boosted their price objective on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Weiss Ratings lowered Corteva from a "hold (c+)" rating to a "hold (c)" rating in a research note on Monday, August 3rd. Morgan Stanley raised their target price on Corteva from $84.00 to $95.00 and gave the stock an "overweight" rating in a research report on Thursday, May 28th. Finally, Oppenheimer lifted their price target on shares of Corteva from $89.00 to $95.00 and gave the stock an "outperform" rating in a research note on Thursday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $91.50.

Corteva Trading Down 0.7%

CTVA stock opened at $82.27 on Friday. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The business's 50 day moving average is $82.58 and its 200-day moving average is $80.52. The firm has a market cap of $54.89 billion, a P/E ratio of 54.48, a P/E/G ratio of 2.54 and a beta of 0.57.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same quarter in the previous year, the firm earned $2.20 EPS. Corteva's quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's dividend payout ratio (DPR) is 47.68%.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source